Kangdong Liu
Overview
Explore the profile of Kangdong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
2246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q, et al.
Mol Cancer
. 2025 Feb;
24(1):51.
PMID: 39994787
As one part of the innate immune response to external stimuli, chronic inflammation increases the risk of various cancers, and tumor-promoting inflammation is considered one of the enabling characteristics of...
2.
Zhang K, Yuan B, Dai X, Chen W, Zhang C, Qiao Y, et al.
Int J Biol Macromol
. 2025 Feb;
306(Pt 1):141249.
PMID: 39984095
Hepatocellular carcinoma (HCC) represents a significant health concern. Identifying novel molecular targets is crucial for clinical diagnosis and targeted treatment of HCC. Aptamers are capable of binding specifically to cancer...
3.
Hussain Z, Zhang Y, Qiu L, Gou S, Liu K
NPJ Vaccines
. 2025 Feb;
10(1):27.
PMID: 39920156
The pivotal role of type 1 conventional dendritic cells (cDC1s) in the field of dendritic cell (DC)-based tumor immunotherapies has been gaining increasing recognition due to their superior antigen cross-presentation...
4.
Wang T, Wang X, Wang K, Yu M, Bai R, Zhang Y, et al.
Proc Natl Acad Sci U S A
. 2025 Jan;
122(5):e2415042122.
PMID: 39869796
Recent studies have demonstrated that chronic stress can enhance the development of multiple human diseases, including cancer. However, the role of chronic stress in esophageal carcinogenesis and its underlying molecular...
5.
Zhang D, Jiang M, Li P, Laster K, Zhao D, Zhi Y, et al.
Cell Rep
. 2025 Jan;
44(1):115135.
PMID: 39772391
The integrated analysis of histone modifier enzymes in solid tumors, especially in esophageal squamous cell carcinoma (ESCC), is still inadequate. Here, we investigate the expression levels of histone modifier enzymes...
6.
Wei H, Zhao D, Zhi Y, Wu Q, Ma J, Xu J, et al.
Adv Sci (Weinh)
. 2025 Jan;
12(8):e2406220.
PMID: 39757767
Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer cases. The lack of effective therapeutic targets makes it difficult to improve the overall survival of patients with...
7.
Jia X, Huang C, Liu F, Dong Z, Liu K
Cell Mol Biol Lett
. 2024 Dec;
29(1):156.
PMID: 39707196
Aberrant elongation of proteins can lead to the activation of oncogenic signaling pathways, resulting in the dysregulation of oncogenic signaling pathways. Eukaryotic elongation factor 2 (eEF2) is an essential regulator...
8.
Fredimoses M, Li P, Zhang Y, Jia H, Liu S, Tian J, et al.
Bioorg Chem
. 2024 Nov;
153:107968.
PMID: 39566271
Novel hydroxamic acid and 3,6-amide modified α-mangostin derivatives were synthesized and evaluated their antiproliferative activities against KYSE 30 (esophageal cancer), HCT 116 (colon cancer), and HGC 27 (gastric cancer) cell...
9.
Zhang J, Wu Q, Xie Y, Li F, Wei H, Jiang Y, et al.
Acta Pharm Sin B
. 2024 Nov;
14(10):4329-4344.
PMID: 39525580
Esophageal squamous cell carcinoma (ESCC), a malignancy of the digestive system, is highly prevalent and the primary cause of cancer-related deaths worldwide due to the lack of early diagnostic biomarkers...
10.
Ma X, Li J, Liu N, Banerjee S, Hu X, Wang X, et al.
Structure
. 2024 Oct;
32(12):2287-2300.e4.
PMID: 39426373
WDR91 and SORF1, members of the WD repeat-containing protein 91 family, control phosphoinositide conversion by inhibiting phosphatidylinositol 3-kinase activity on endosomes, which promotes endosome maturation. Here, we report the crystal...